MDGL Jul 2024 290.000 put
- Simply Wall St.
Unveiling Three US Growth Companies With High Insider Ownership
As the Nasdaq and S&P 500 continue to set records, reflecting a robust appetite for growth among investors, it's an opportune time to explore companies where high insider ownership aligns closely with corporate ambitions and investor interests. In this context, firms with substantial insider stakes can be particularly compelling, as they often signal confidence from those who know the company best.
- Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
Madrigal Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
- GlobeNewswire
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosisNoninvasive test data through three years of treatment demonstrate durable treatment response to Rezdiffra; 91% of patients achieved improvement or stabilization of liver stiffness First analysis of health-related quality of life data from MAESTRO-NASH demonstrates Rezdiffra improved patient worry, health distress and stigm
